Table 2.
Univariate analysis of clinicopathological factors for the overall survival in NSCLC patients
| Variables | Overall survival time (months)
|
P-value | |
|---|---|---|---|
| Mean±SD | Median | ||
| Sex | 0.788 | ||
| Male | 43.27±2.33 | 44.70 | |
| Female | 42.00±3.61 | 45.00 | |
| Age (years) | 0.399 | ||
| ≤60 | 45.65±2.38 | 46.30 | |
| >60 | 39.48±3.23 | 40.10 | |
| Smoking | 0.171 | ||
| Yes | 43.68±2.80 | 44.80 | |
| No | 41.92±2.70 | 42.80 | |
| Tumor size (cm) | 0.480 | ||
| ≤3 | 45.90±2.80 | 46.30 | |
| >3 | 40.91±2.69 | 42.30 | |
| Histological type | 0.929 | ||
| Adenocarcinoma | 42.34±2.73 | 43.30 | |
| Squamous cell carcinoma | 43.69±2.83 | 44.30 | |
| Differentiation | <0.001 | ||
| Well/moderate | 52.26±1.74 | 52.40 | |
| Poor | 26.32±3.10 | 28.00 | |
| LN metastasis | <0.001 | ||
| Negative | 54.36±1.76 | NR | |
| Positive | 27.37±2.79 | 28.12 | |
| TNM stage | <0.001 | ||
| I | 61.21±2.35 | NR | |
| II | 51.49±1.75 | 49.40 | |
| III | 30.54±2.42 | 31.00 | |
| FOXM1 expression | <0.001 | ||
| Negative | 54.57±2.73 | NR | |
| Positive | 38.07±2.38 | 39.20 | |
Abbreviations: NSCLC, non-small cell lung carcinoma; LN, lymph node; TNM, tumor-node-metastasis; NR, not reported.